MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1055-9965.epi-14-1062

Медицинская библиотека · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015

Development and validation of a melanoma risk score based on pooled data from 16 case-control studies.

Davies John R, Chang Yu-mei, Bishop D Timothy, Armstrong Bruce K, Bataille Veronique, Bergman Wilma, Berwick Marianne, Bracci Paige M, Elwood J Mark, Ernstoff Marc S, Green Adele, Gruis Nelleke A, Holly Elizabeth A, Ingvar Christian, Kanetsky Peter A, Karagas Margaret R, Lee Tim K, Le Marchand Loïc, Mackie Rona M, Olsson Håkan, Østerlind Anne, Rebbeck Timothy R, Reich Kristian, Sasieni Peter, Siskind Victor, Swerdlow Anthony J, Titus Linda, Zens Michael S, Ziegler Andreas, Gallagher Richard P, Barrett Jennifer H, Newton-Bishop Julia

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАВалидационное исследованиеПеревод в очереди

Аннотация

BACKGROUND

We report the development of a cutaneous melanoma risk algorithm based upon seven factors; hair color, skin type, family history, freckling, nevus count, number of large nevi, and history of sunburn, intended to form the basis of a self-assessment Web tool for the general public.

METHODS

Predicted odds of melanoma were estimated by analyzing a pooled dataset from 16 case-control studies using logistic random coefficients models. Risk categories were defined based on the distribution of the predicted odds in the controls from these studies. Imputation was used to estimate missing data in the pooled datasets. The 30th, 60th, and 90th centiles were used to distribute individuals into four risk groups for their age, sex, and geographic location. Cross-validation was used to test the robustness of the thresholds for each group by leaving out each study one by one. Performance of the model was assessed in an independent UK case-control study dataset.

RESULTS

Cross-validation confirmed the robustness of the threshold estimates. Cases and controls were well discriminated in the independent dataset [area under the curve, 0.75; 95% confidence interval (CI), 0.73-0.78]. Twenty-nine percent of cases were in the highest risk group compared with 7% of controls, and 43% of controls were in the lowest risk group compared with 13% of cases.

CONCLUSION

We have identified a composite score representing an estimate of relative risk and successfully validated this score in an independent dataset.

IMPACT: This score may be a useful tool to inform members of the public about their melanoma risk.

Для цитирования: Davies John R, Chang Yu-mei, Bishop D Timothy, Armstrong Bruce K, Bataille Veronique, Bergman Wilma, Berwick Marianne, Bracci Paige M, Elwood J Mark, Ernstoff Marc S, Green Adele, Gruis Nelleke A, Holly Elizabeth A, Ingvar Christian, Kanetsky Peter A, Karagas Margaret R, Lee Tim K, Le Marchand Loïc, Mackie Rona M, Olsson Håkan, Østerlind Anne, Rebbeck Timothy R, Reich Kristian, Sasieni Peter, Siskind Victor, Swerdlow Anthony J, Titus Linda, Zens Michael S, Ziegler Andreas, Gallagher Richard P, Barrett Jennifer H, Newton-Bishop Julia. Development and validation of a melanoma risk score based on pooled data from 16 case-control studies.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015. DOI: 10.1158/1055-9965.epi-14-1062.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.